Alzheimer’s Disease – Monday Morning

Links between Alzheimer’s disease and viruses are building. But decades of soul-crushing frustration for patients and scientists suggest that this latest finding might go the way of its forerunners.

Steve Walker July 9, 2018 No Comments

The News: It has long been a controversial theory about Alzheimer’s disease (AD), often dismissed by experts as a random detour from mainstream research. But a new study by a team that… Read more »

Tag Archives: Alzheimer’s Disease

Europe bursts onto the biotech scene as Grifols’ Phase 2b/3 plasma replacement therapy works in Alzheimer’s patients. Buy, sell or hold?

Atrial fibrillation increases risk of dementia by 40%, Swedish study shows. Bring on those blood thinners, say researchers.

Researchers say autobiographical memory test may foretell Alzheimer’s risk. Study invokes friends, relatives and sparks uneasy self-reflection.

Forget about Biogen/Eisai’s promising new drug for Alzheimer’s; Study says aggressive blood-pressure treatment with existing meds reduces dementia/AD risk.

Tiny Swedish biotech not taking back seat to US in Alzheimer’s race. How to buy it.

Links between Alzheimer’s disease and viruses are building. But decades of soul-crushing frustration for patients and scientists suggest that this latest finding might go the way of its forerunners.

Investors pour $76 million into B round for Cortexyme’s “new” approach to Alzheimer’s. No, it doesn’t target Amyloid beta (Aβ); it’s bacterial and getting support from Pfizer, Paul Allen.

New advance directives permit dementia patients to refuse eating — no matter what — thereby nullifying the competence conundrum and avoiding “unwanted care.” About time.

Coffee drinkers stunned as new study suggests caffeine consumption worsens Alzheimer’s symptoms. Now what?

Heath stock take it on the chin while immuno-oncology IPOs keep a coming.